[HTML][HTML] Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases
EMA Rabelo-Gonçalves, BM Roesler… - World journal of …, 2015 - ncbi.nlm.nih.gov
Helicobacter pylori (H. pylori) is an ancient microorganism that has co-evolved with humans
for over 60000 years. This bacterium typically colonizes the human stomach and it is …
for over 60000 years. This bacterium typically colonizes the human stomach and it is …
Extradigestive manifestations of Helicobacter pylori gastric infection
In the past year, several studies have been carried out on the association between
Helicobacter pyloriinfection and a miscellany of extradigestive diseases, such as …
Helicobacter pyloriinfection and a miscellany of extradigestive diseases, such as …
[图书][B] Hepatology Principles and Practice: History· Morphology Biochemistry· Diagnostics Clinic· Therapy
E Kuntz - 2006 - Springer
Metabolic processes utilize a variety of differing and contrasting biochemical routes to
enable synthesis of degradation and activation or deactivation of substances; in addition …
enable synthesis of degradation and activation or deactivation of substances; in addition …
Identification of Helicobacter pylori and OtherHelicobacter Species by PCR, Hybridization, and Partial DNA Sequencing in Human Liver Samples from Patients with …
HO Nilsson, J Taneera, M Castedal… - Journal of clinical …, 2000 - Am Soc Microbiol
Helicobacter pylori was identified in human liver tissue by PCR, hybridization, and partial
DNA sequencing. Liver biopsies were obtained from patients with primary sclerosing …
DNA sequencing. Liver biopsies were obtained from patients with primary sclerosing …
[HTML][HTML] Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma
R Pellicano, V Mazzaferro, WF Grigioni… - World Journal of …, 2004 - ncbi.nlm.nih.gov
AIM: Only a minority of patients carrying a defined viral aetiologic agent develop cirrhosis
and ultimately hepatocellular carcinoma (HCC), the mechanism underlying the worsening is …
and ultimately hepatocellular carcinoma (HCC), the mechanism underlying the worsening is …
Helicobacter species and hepatobiliary diseases
RWL Leong, JJY Sung - Alimentary pharmacology & …, 2002 - Wiley Online Library
Helicobacter species, which may colonize the biliary tract, have been implicated as a
possible cause of hepatobiliary diseases ranging from chronic cholecystitis and primary …
possible cause of hepatobiliary diseases ranging from chronic cholecystitis and primary …
Enhanced anti-ulcer effect of pioglitazone on gastric ulcers in cirrhotic rats: the role of nitric oxide and IL-1β
Background The frequency of gastrointestinal ulcerations is higher in cirrhotic patients than
in the normal population. It has been shown that pioglitazone exhibits gastroprotective …
in the normal population. It has been shown that pioglitazone exhibits gastroprotective …
Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker?
A Ponzetto, R Pellicano, N Leone, MA Cutufia… - Medical hypotheses, 2000 - Elsevier
Since it has been shown that Helicobacter hepaticus causes both chronic hepatitis and
hepatocellular carcinoma (HCC) in mice, it is suggested that differences in the progression …
hepatocellular carcinoma (HCC) in mice, it is suggested that differences in the progression …
[HTML][HTML] Distinctive aspects of peptic ulcer disease, Dieulafoy's lesion, and Mallory-Weiss syndrome in patients with advanced alcoholic liver disease or cirrhosis
B Nojkov, MS Cappell - World journal of gastroenterology, 2016 - ncbi.nlm.nih.gov
AIM: To systematically review the data on distinctive aspects of peptic ulcer disease (PUD),
Dieulafoy's lesion (DL), and Mallory-Weiss syndrome (MWS) in patients with advanced …
Dieulafoy's lesion (DL), and Mallory-Weiss syndrome (MWS) in patients with advanced …
[HTML][HTML] Proton pump inhibitors in cirrhosis: tradition or evidence based practice?
F Lodato, F Azzaroli, M Di Girolamo… - World Journal of …, 2008 - ncbi.nlm.nih.gov
Abstract Proton Pump Inhibitors (PPI) are very effective in inhibiting acid secretion and are
extensively used in many acid related diseases. They are also often used in patients with …
extensively used in many acid related diseases. They are also often used in patients with …